- Home
- CRGX vs VLGEA Comparison
CRGX vs VLGEA Comparison
Compare CRGX & VLGEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- VLGEA
- Stock Information
- Founded
- CRGX 2021
- VLGEA 1937
- Country
- CRGX United States
- VLGEA United States
- Employees
- CRGX N/A
- VLGEA N/A
- Industry
- CRGX
- VLGEA Food Chains
- Sector
- CRGX
- VLGEA Consumer Staples
- Exchange
- CRGX Nasdaq
- VLGEA Nasdaq
- Market Cap
- CRGX 621.4M
- VLGEA 594.9M
- IPO Year
- CRGX 2023
- VLGEA N/A
- Fundamental
- Price
- CRGX $13.46
- VLGEA $33.27
- Analyst Decision
- CRGX Strong Buy
- VLGEA
- Analyst Count
- CRGX 6
- VLGEA 0
- Target Price
- CRGX $31.80
- VLGEA N/A
- AVG Volume (30 Days)
- CRGX 231.3K
- VLGEA 27.3K
- Earning Date
- CRGX 03-20-2025
- VLGEA 03-04-2025
- Dividend Yield
- CRGX N/A
- VLGEA 3.01%
- EPS Growth
- CRGX N/A
- VLGEA 2.47
- EPS
- CRGX N/A
- VLGEA 3.48
- Revenue
- CRGX N/A
- VLGEA $2,257,909,000.00
- Revenue This Year
- CRGX N/A
- VLGEA N/A
- Revenue Next Year
- CRGX N/A
- VLGEA N/A
- P/E Ratio
- CRGX N/A
- VLGEA $9.56
- Revenue Growth
- CRGX N/A
- VLGEA 3.42
- 52 Week Low
- CRGX $10.91
- VLGEA $24.57
- 52 Week High
- CRGX $33.92
- VLGEA $33.99
- Technical
- Relative Strength Index (RSI)
- CRGX 47.00
- VLGEA 59.18
- Support Level
- CRGX $12.51
- VLGEA $32.19
- Resistance Level
- CRGX $15.75
- VLGEA $33.23
- Average True Range (ATR)
- CRGX 1.09
- VLGEA 1.04
- MACD
- CRGX 0.17
- VLGEA 0.17
- Stochastic Oscillator
- CRGX 52.74
- VLGEA 97.32
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.